Tag: az

Lancet: “Overall mortality was lower in the hydroxychloroquine group”. Study, Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study

21/09/2020 No Comments

Source: The Lancet Summary Background Hydroxychloroquine is one of several agents being evaluated in the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Ghana: “HCQ and AZ associated with viral clearance in COVID-19 patients.” Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study

15/09/2020 No Comments

HCQ or CQ should be used efficiently alone or in combination with AZ to optimize the management of asymptomatic and mild cases of COVID-19.

France Study: Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time

02/08/2020 No Comments

Indeed, our study suggests that AZI±HCQ might have impacted COVID-19 outcome in a population of patients, optimal timing of treatment interventions to study

The Palmer Foundation

Tag: az

Lancet: “Overall mortality was lower in the hydroxychloroquine group”. Study, Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study

Ghana: “HCQ and AZ associated with viral clearance in COVID-19 patients.” Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study

France Study: Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time

Copyright 2020 © The Palmer Foundation